Results 41 to 50 of about 555 (124)
ПРИМЕНЕНИЕ МУКОАКТИВНЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ В ПРАКТИКЕ ТЕРАПЕВТА
Russia is among the countries where using of mucolytic drugs in clinical practice is widespread. In chronic bronchitis, chronic obstructive pulmonary disease, acute respiratory syndrome with prolonged cough, pneumonia, tuberculosis and many other ...
Ф. Т. Малыхин +2 more
doaj +1 more source
Abstract Objective To investigate current odontological care routines for patients treated for head and neck cancers in the county councils/regions (C/Rs) of Sweden. Methods An invitation to fill in a web‐based questionnaire was sent to dentists/dental hygienists working in dental clinics in the 12 C/Rs, treating and responsible for the odontological ...
Niklas Bohm +3 more
wiley +1 more source
Acute bronchitis: clinical guidelines
The article deals with the issues of epidemiology and pharmacotherapy of acute bronchitis in adults. Acute bronchitis is one of the most pressing challenges in modern pulmonology, which is associated with a high incidence reaching 30–40 ‰ every year. The
A. A. Zaitsev
doaj +1 more source
Background: Chronic rhinitis in cats represents a persistent inflammatory condition of the upper respiratory tract, frequently complicated by secondary bacterial infections and exacerbated by comorbidities, such as ectoparasite infestations.
Luh Gede Tasya Pradnya Prastistha +2 more
doaj +1 more source
Effects of long-term prophylaxis with bromhexine hydrochloride and treatment with high colchicine doses of COVID-19 [PDF]
In a series of publications, we attempt to demonstrate the prophylactic role of bromhexine hydrochloride (BHH) and the curative role of high colchicine doses against COVID-19.
Krasimir Marinov +4 more
doaj +3 more sources
Non‐Pulmonary Mechanisms of Action of Ambroxol in In Vivo Experimental Models: a Systematic Review
ABSTRACT Background Repositioning offers a cost‐effective approach to discovering new therapeutic applications for existing medications. Ambroxol, primarily used as a mucolytic for respiratory diseases, has demonstrated anti‐inflammatory, analgesic, and antioxidant properties, suggesting potential benefits in non‐pulmonary conditions.
Michelline Joana Tenório Albuquerque Madruga Mesquita +13 more
wiley +1 more source
Pilot survey among patients taking bromhexine prophylactically against influenza
Background: The successful use of bromhexine hydrochloride (BRH) for COVID-19 prevention led us to apply the same method for flu prevention. The goal of this study is to observe whether BRH could protect people against influenza.
Vanyo Mitev +11 more
doaj +1 more source
Abstract Cognitive impairment affects around 19% of community‐dwelling older adults in the United States. Pharmacists can play a significant role in identifying and deprescribing cognitive‐impairing medications through cognitive‐focused medication reviews or as part of comprehensive medication management.
Jacob Stanton +4 more
wiley +1 more source
Abstract Living evidence methods, such as those used to produce living guidelines, can evolve over time as the context or evidence changes. In Australia, the National Clinical Evidence Taskforce has been developing living guidelines for the management and care of people with coronavirus disease 2019 (COVID‐19) since March 2020, undertaking daily ...
Heath White +12 more
wiley +1 more source
This study successfully developed a novel potentiometric sensor for Bromhexine Hydrochloride (BHH) detection using a coated graphite electrode integrated with crystalline copper nanoparticles (CuNPs) synthesized via a green approach.
Muner Hamed +2 more
doaj +1 more source

